Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis

PHASE4CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

November 30, 2015

Conditions
Relapsing-Remitting Multiple Sclerosis
Interventions
DRUG

dimethyl fumarate

DRUG

acetylsalicylic acid

enteric-coated capsule

DRUG

ASA-Placebo

matched placebo

Trial Locations (21)

Unknown

Research Site, Cork

Dublin 4

Research Site, Dublin

Dublin 7

Research Site, Dublin

Dublin 9

Research Site, Dublin

RG24 9NA

Research Site, Basingstoke

B15 2TH

Research Site, Birmingham

CF14 4XW

Research Site, Cardiff

EHA 2XU

Research Site, Edinburgh

EX2 5DW

Research Site, Exeter

G51 4TH

Research Site, Glasgow

LE5 4PW

Research Site, Leicester

L9 7LJ

Research Site, Liverpool

SE5 9RS

Research Site, London

SW17 0QT

Research Site, London

WC1N 3BG

Research Site, London

NE1 4LP

Research Site, Newcastle upon Tyne

NR4 7UY

Research Site, Norwich

NG7 2UH

Research Site, Nottingham

PL6 8BX

Research Site, Plymouth

M6 8HD

Research Site, Salford

SA6 6NL

Research Site, Swansea

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY